文献速递妇科生殖医学

抗苗勒管激素水平与年轻多囊卵巢综合征女性心脏代谢风险的关系

Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
PubMed 文献 · Fertil Steril · 2016-11-11

本研究为横断面研究,纳入252例18-46岁多囊卵巢综合征(PCOS)女性,探讨抗苗勒管激素(AMH)水平与代谢综合征(MetSyn)的关联。结果显示AMH中位数为5.1 ng/mL(四分位距3.0-8.1),MetSyn患病率为23.8%;AMH每降低1个单位,MetSyn风险增加11%(OR 1.11,95%CI 1.03-1.20),多变量调整后仍维持(OR 1.09,95%CI 1.01-1.18)。作者认为低AMH水平预测年轻PCOS女性MetSyn风险更高。

要点

  • 年轻PCOS女性中,AMH每降低1个单位,MetSyn风险增加11%(OR 1.11,95%CI 1.03-1.20)。
  • AMH最低三分位组较高三分位组MetSyn风险增加约2倍(调整OR 2.1,95%CI 1.01-4.3)。
  • 总睾酮水平与MetSyn及其各组分均无关联。

核心结论

  • 在年轻PCOS女性中,低AMH水平预测更高的MetSyn风险。
  • AMH作为卵巢储备标志物在肥胖PCOS女性心脏代谢风险分层中的作用需在纵向研究和围绝经期人群中进一步明确。

研究设计与样本

  • 横断面研究,纳入252例18-46岁PCOS女性,来自学术性PCOS中心。
  • 无干预措施。

主要发现

  • AMH中位数为5.1 ng/mL(四分位距3.0-8.1),MetSyn患病率为23.8%。
  • AMH与总睾酮、高密度脂蛋白胆固醇和SHBG呈正相关,与空腹血糖、胰岛素抵抗稳态模型评估、体重指数、收缩压和舒张压呈负相关。
  • AMH每降低1个单位,MetSyn风险增加11%(OR 1.11,95%CI 1.03-1.20);调整年龄和种族的多变量模型中关联强度维持(OR 1.09,95%CI 1.01-1.18)。
  • AMH最低三分位组较高三分位组MetSyn风险增加约2倍(调整OR 2.1,95%CI 1.01-4.3)。
  • 总睾酮与MetSyn及其各组分均无关联。

局限性

  • 原文指出AMH在肥胖PCOS女性心脏代谢风险分层中的作用需在纵向研究和围绝经期人群中进一步明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the association between antimüllerian hormone (AMH) levels and metabolic syndrome (MetSyn) in young women with polycystic ovary syndrome (PCOS). DESIGN: Cross-sectional study. SETTING: Academic PCOS center. PATIENT(S): A total of 252 women aged 18-46 years with PCOS. INTERVENTION: None. MAIN OUTCOME MEASURE(S): Association of AMH with markers of cardiometabolic risk and MetSyn. RESULT(S): The median AMH level was 5.1 ng/mL (interquartile range [IQR] 3.0-8.1), and prevalence of MetSyn was 23.8%. AMH levels positively correlated with total T, high-density lipoprotein (HDL) cholesterol, and SHBG and negatively correlated with fasting glucose, homeostasis-model assessment of insulin resistance, body mass index (BMI), and systolic and diastolic blood pressure. A single-unit decrease in AMH was associated with an 11% increase in odds of MetSyn (odds ratio [OR] 1.11, 95% confidence interval [CI] 1.03-1.20); the strength of this association was maintained in the multivariate model (OR 1.09, 95% CI 1.01-1.18) adjusting for age and race. Subjects with AMH values in the lowest tertile were twice as likely as those in the highest tertile to have MetSyn (adjusted OR 2.1, 95% CI 1.01-4.3). Total T was not associated with MetSyn or its individual components. CONCLUSION(S): Our findings indicate that in young women with PCOS, low AMH levels predict a greater risk of MetSyn. The role of AMH, an established biomarker of ovarian reserve, in risk stratification of cardiometabolic risk in obese women with PCOS needs to be clarified in longitudinal studies and in the perimenopausal population.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Feldman RA, O'Neill K, Butts SF, et al. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome. Fertil Steril. 2016. PMID: 27842995. doi:10.1016/j.fertnstert.2016.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。